Rabbit syndrome: Developed after increasing the dosage of quetiapine in a patient using quetiapine with duloxetine

Basit Öğe Kaydı
dc.authoridkartalcı, şükrü/0000-0003-2560-0355
dc.authoridKarlıdağ, Rifat/0000-0002-3650-0774;
dc.authorwosidkartalcı, şükrü/ABI-1106-2020
dc.authorwosidYang, Xinzi/KVC-3853-2024
dc.authorwosidKarlıdağ, Rifat/AAB-4281-2021
dc.authorwosidkarlıdağ, rıfat/AAB-4255-2021
dc.contributor.authorCumurcu, Birgul Elbozan
dc.contributor.authorAlmis, Behice Han
dc.contributor.authorKartalci, Sukru
dc.contributor.authorKarlidag, Rifat
dc.date.accessioned2024-08-04T20:35:41Z
dc.date.available2024-08-04T20:35:41Z
dc.date.issued2011
dc.departmentİnönü Üniversitesien_US
dc.description.abstractRabbit syndrome: Developed after increasing the dosage of quetiapine in a patient using quetiapine with duloxetine Fifty-six years old, female patient who was being followed and treated for resistant depression, had been using duloxetine 60 mg/day and quetiapine 300 mg/day for 3 months. After 2 weeks the quetiapine dose was increased to 600 mg/day because of resistant depression concomitant with insomnia. A movement disorder was observed, appearing as a rhythmic tremor in the perioral muscles which was defined by the patient as involuntary. This involuntary rhythmic perioral tremor was diagnosed as rabbit syndrome and for this reason quetiapine, the only antipsychotic used by the patient, was gradually decrease in dose and eventually stopped. Four weeks after stopping the quetiapine, the patient's involuntary perioral rhythmic movements decreased from four to zero points, according to the lips and perioral subgroup of the Abnormal Involuntary Movements Scale (AIMS).en_US
dc.identifier.doi10.5455/bcp.20110926113728
dc.identifier.endpage361en_US
dc.identifier.issn1017-7833
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-82255181922en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage359en_US
dc.identifier.urihttps://doi.org/10.5455/bcp.20110926113728
dc.identifier.urihttps://hdl.handle.net/11616/95497
dc.identifier.volume21en_US
dc.identifier.wosWOS:000297959300010en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.publisherKure Iletisim Grubu A Sen_US
dc.relation.ispartofKlinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectQuetiapineen_US
dc.subjectrhythmic perioral tremoren_US
dc.subjectrabbit syndromeen_US
dc.titleRabbit syndrome: Developed after increasing the dosage of quetiapine in a patient using quetiapine with duloxetineen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu